HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ambrisentan

RN given for the ((+-)-2S)-isomer; an ET(A) receptor antagonist and antihypertensive agent; studied for use as in pulmonary arterial hypertension
Also Known As:
BSF 208075; BSF-208075; BSF208075; Gilead brand of ambrisentan; LU 208075; LU-208075; LU208075; Letairis; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid
Networked: 73 relevant articles (9 outcomes, 18 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Rubin, Lewis J: 5 articles (03/2014 - 07/2005)
2. Behr, Juergen: 4 articles (11/2015 - 05/2013)
3. Martinez, Fernando J: 3 articles (11/2015 - 05/2013)
4. Shao, Lixin: 3 articles (11/2015 - 05/2013)
5. O'Riordan, Thomas G: 3 articles (11/2015 - 05/2013)
6. Flaherty, Kevin R: 3 articles (11/2015 - 05/2013)
7. Wells, Athol U: 3 articles (11/2015 - 05/2013)
8. Raghu, Ganesh: 3 articles (11/2015 - 05/2013)
9. Brown, Kevin K: 3 articles (11/2015 - 05/2013)
10. Shapiro, Shelley: 3 articles (11/2012 - 08/2005)

Related Diseases

1. Dyspnea (Shortness of Breath)
2. Hypertension (High Blood Pressure)
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Systemic Scleroderma (Systemic Sclerosis)
5. Ulcer

Related Drugs and Biologics

1. Idiopathic pulmonary hypertension
2. Endothelin Receptors (Endothelin Receptor)
3. Endothelin-1 (Endothelin 1)
4. bosentan (Tracleer)
5. sitaxsentan
6. Collagen
7. tadalafil (Cialis)
8. Endothelins (Endothelin)
9. ambrisentan
10. treprostinil

Related Therapies and Procedures

1. Lasers (Laser)
2. Warm Ischemia
3. Organ Transplantation
4. Pancreas Transplantation
5. Stents